An interaction between EpCAM and claudin 1 has not yet been demonstrated in breast cancer but a similar interaction may account for one of the mechanisms by which high levels of claudin 1 accumulate in the cytoplasm of some aggressive breast cancer cell lines and tumors, and warrants further investigation. Here, CLDN1 is linked to breast cancer.